The proprotein convertase FURIN is a novel aneurysm predisposition gene impairing TGF-β signaling.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
18 Apr 2024
Historique:
received: 31 05 2023
revised: 18 01 2024
accepted: 25 02 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: aheadofprint

Résumé

Aortic aneurysms (AA) frequently involve dysregulation of transforming growth factor β (TGF-β)-signaling in the aorta. Here, FURIN was tested as aneurysm predisposition gene given its role as proprotein convertase in pro-TGF-β maturation. Rare FURIN variants were detected by whole-exome sequencing of 781 unrelated aortic aneurysm patients and affected relatives. Thirteen rare heterozygous FURIN variants occurred in 3.7% (29) unrelated index AA patients, of which 72% had multiple aneurysms or a dissection.FURIN maturation and activity of these variants were decreased in vitro. Patient-derived fibroblasts showed decreased pro-TGF-β processing, phosphorylation of downstream effector SMAD2 and kinases ERK1/2, and steady-state mRNA levels of the TGF-β-responsive ACTA2 gene. In aortic tissue, collagen and fibrillin fibers were affected. One variant (R745Q), observed in 10 unrelated cases, affected TGF-β signaling variably, indicating effect modification by individual genetic backgrounds. FURIN is a novel, frequent genetic predisposition for abdominal-, thoracic-, and multiple aortic or middle sized artery aneurysms in older patients, by affecting intracellular TGF-β signaling, depending on individual genetic backgrounds.

Identifiants

pubmed: 38636100
pii: 7651189
doi: 10.1093/cvr/cvae078
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Zongsheng He (Z)

Department of Human Genetics, KU Leuven, Leuven, B-3000, Belgium.

Arne S IJpma (AS)

Departments of Pathology, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Dianne Vreeken (D)

Cardiology, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Daphne Heijsman (D)

Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Karen Rosier (K)

Department of Human Genetics, KU Leuven, Leuven, B-3000, Belgium.

Hence J M Verhagen (HJM)

Surgery, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Jorg de Bruin (J)

Surgery, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Hennie T Brüggenwirth (HT)

Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Jolien W Roos-Hesselink (JW)

Cardiology, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Jos A Bekkers (JA)

Cardiothoracic Surgery, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Danny Huylebroeck (D)

Cell Biology, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Heleen van Beusekom (H)

Cardiology, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

John W M Creemers (JWM)

Department of Human Genetics, KU Leuven, Leuven, B-3000, Belgium.

Danielle Majoor-Krakauer (D)

Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, 3015 GD, the Netherlands.

Classifications MeSH